NHANES General Chemistry Laboratory Testing 2025-2030
ID: 75D30125R00073Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/b1c3c04d1e7e4ba4ae6c4497a694b9d6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for the NHANES General Chemistry Laboratory Testing contract, which will span from February 14, 2025, to February 13, 2030. The primary objective of this procurement is to obtain Clinical Laboratory Improvement Amendments (CLIA) certified laboratory measurements on biological specimens collected through the National Health and Nutrition Examination Survey (NHANES), which aims to provide national statistics on the health and nutritional status of the U.S. population. This contract is crucial for generating national estimates and monitoring trends in chronic diseases, with the contractor responsible for conducting a variety of chemistry tests, including a Comprehensive Metabolic Panel and lipid panels, while ensuring strict confidentiality and compliance with ethical standards. Interested offerors must submit their proposals electronically by the specified deadlines, with a focus on demonstrating technical capabilities and relevant past performance, and can contact David Santimaw at zgm2@cdc.gov or 770-488-5282 for further information.

    Point(s) of Contact
    David Santimaw
    (770) 488-5282
    zgm2@cdc.gov
    Arianna Williams
    (770) 488-5036
    xsm2@cdc.gov
    Files
    Title
    Posted
    Attachment 1 - Statement of Work.pdf
    This Statement of Work outlines the requirements for the NHANES General Chemistry Laboratory Testing contract for the period from February 14, 2025, to February 13, 2030. The National Health and Nutrition Examination Survey (NHANES) aims to assess the health and nutritional status of the U.S. population by analyzing biological specimens. The contractor will be responsible for conducting various chemistry tests, including a Comprehensive Metabolic Panel, additional chemistry tests, high-sensitivity C-reactive protein assessments, and urinary analyses. The contractor must be CLIA-certified and adhere to strict quality control measures, reporting results within 21 days. Key deliverables involve receiving and analyzing samples, developing laboratory procedure manuals, and submitting quarterly reports. A systematic and high-volume testing process is anticipated, with thousands of samples expected annually. The contractor must maintain confidentiality and comply with ethical standards surrounding human subjects. In conclusion, this contract emphasizes the government's commitment to public health monitoring through rigorous laboratory testing and analysis, ensuring that guidelines and standards are met throughout the performance period.
    Attachment 2 - Section L - Instructions to Offerors.pdf
    The document outlines the instructions for submitting proposals in response to the government solicitation RFP Number 75D30125R00073, aimed at awarding an Indefinite Delivery Indefinite Quantity (IDIQ) contract with a Firm Fixed Pricing structure. It emphasizes the importance of electronic submission via email, specifies proposal format requirements, and delineates the evaluation criteria based on best value trade-off procedures. Proposals must address technical capabilities, past performance, and pricing explicitly, with distinct volume limits for each proposal section. Key components include the need to be registered in the System for Award Management, and adherence to specified page limits: 100 pages for the Technical Proposal, 15 for Past Performance, and no limit for the Price Proposal as long as it's in the designated format. Offerors are instructed to highlight technical approaches, identify potential risks, provide past performance details relevant to the contract scope, and submit financial data in accordance with strict guidelines. Overall, the document serves to ensure compliance and clarity for potential bidders while fostering a competitive selection process for government contracting.
    Attachment 2 - Section L - Instructions to Offerors - Final.pdf
    This government document outlines instructions for submitting a proposal in response to solicitation RFP Number 75D30125R00073, intending to award an Indefinite Delivery Indefinite Quantity (IDIQ) contract with firm fixed prices under FAR regulations. Proposals must be submitted electronically by specified deadlines, and only via email. The proposal consists of three volumes: Volume I contains the Technical Proposal and Past Performance, with strict page limits for each subfactor. The Technical Proposal must detail the offeror's approach to fulfilling contract requirements, including technical capabilities and facilities, without referencing pricing. Past Performance must include relevant contracts from the past three years, including references. Volume II is solely for price information and must adhere to specific formatting rules. Key points include the need to demonstrate technical expertise, compliance with relevant regulations, and the submission of past performance information, ensuring that all proposals meet formatting and submission criteria. The government retains the right to award contracts without discussions based on initial proposals, emphasizing the importance of quality in these submissions.
    Attachment 3 - Section M - Evaluation Basis for Award.pdf
    The addendum outlines the evaluation criteria for awarding a federal contract through a best value tradeoff process aimed at identifying the most competent offeror who meets the CDC's requirements effectively and affordably. The award will be made to the responsible offeror whose proposal meets all RFP conditions and exhibits acceptable past performance. The evaluation process involves assessing compliance with solicitation instructions, examining technical capabilities, analyzing past performance (on an acceptable/unacceptable basis), and reviewing price submissions. The technical evaluation focuses on two main subfactors: the technical approach, including necessary laboratory compliance and capability, and the facilities and equipment available for contract performance. Offerors must present a strong, risk-aware proposal that meets the Government’s requirements to be considered technically acceptable. Past performance evaluation will consider only recent and relevant contracts. Pricing will be reviewed for reasonableness, balance, and total evaluated price, which includes calculations for potential contract extensions. Overall, the document emphasizes the importance of technical solutions over costs in the award decision, underscoring professionalism and thoroughness throughout the evaluation process. This process is essential in ensuring effective procurement and contract management for government contracts.
    Attachment 4 - Price Proposal Volume.xlsx
    The document outlines a Request for Proposal (RFP) for the NHANES General Chemistry Lab Testing project, detailing the contract's structure for laboratory services. It specifies the activities and deliverables, including laboratory tests such as the Comprehensive Metabolic Panel and specific markers like Cystatin-C and hs-CRP among others. The document consists of various Contract Line Item Numbers (CLINs) for base and option periods, where each CLIN correlates with different lab tests, procedures, and reporting requirements. Units, total prices, and costs are indicated but left blank, suggesting a need for bidders to propose pricing. Additionally, there are provisions for collaboration with the NCHS data collection contractor and requirements for quarterly reporting and laboratory manuals. This RFP aims to solicit competitive proposals for laboratory testing services essential for the NHANES project, supporting public health research and initiatives in the context of federal grant funding mechanisms.
    Attachment 5 - Past Performance Questionnaire Survey.pdf
    The document pertains to a Past/Present Performance Reference Questionnaire related to Solicitation No. 75D30125R00073, which is part of federal procurement processes. It outlines instructions for offerors to complete a questionnaire that assesses their past performance on contracts. Offerors must identify three business references, detailing their names, contact information, contract specifics, and descriptions of services performed. The questionnaire is designed to collect feedback on the contractor's compliance with delivery schedules, business practices, quality of service, and overall performance. Respondents are asked to rate various aspects on a scale ranging from Poor to Excellent. The document emphasizes the need for offerors to submit a cover letter that allows for discussion of their performance and to provide all required information by a specified deadline (January 9, 2025). This process is critical for evaluating contractors’ previous work, which informs decisions in federal contracting activities, ensuring accountability and quality in public procurement. The focus is on obtaining objective assessments from previous clients to support the evaluation of prospective contractors.
    Solicitation - 75D30125R00073.pdf
    The document outlines a solicitation for commercial items from the Centers for Disease Control and Prevention (CDC), focusing on laboratory services for conducting a series of biochemical tests over multiple performance periods, from January 2025 through January 2030. It specifies the required services, including comprehensive metabolic panels, cystatin-C, various liver function tests, lipid panels, and urinary analyses. Each service includes specific quantities of tests, with performance bases defined for each component. The document details the acquisition of these services, inviting qualified contractors to submit proposals in response to the outlined requirements. It incorporates essential federal acquisition regulations and definitions, emphasizing compliance with relevant laws, ethical conduct regarding procurement, and the need for effective record management in handling federal documents. Moreover, the solicitation highlights the contract administration process, roles of key personnel, and obligations under the contract, such as the prohibition of personal services, adherence to non-disclosure agreements, and the importance of electronic payment processing. Overall, the document serves to facilitate a transparent procurement process for vital health services while ensuring governmental regulations regarding contracting and data management are upheld.
    Lifecycle
    Title
    Type
    NHANES General Chemistry Laboratory Testing 2025-2030
    Currently viewing
    Solicitation
    Similar Opportunities
    Synopsis of Proposed Contract Action
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for a contract focused on the development and testing of systems for the National Health and Nutrition Examination Survey (NHANES) chemistry data. The primary objectives include performing laboratory testing, specifically for a Comprehensive Metabolic Panel (CMP) and additional biochemical tests, while ensuring compliance with CLIA regulations and submitting results within 21 days of sample receipt. This initiative is crucial for enhancing public health data collection and management, with an estimated annual workload of 3,000 to 5,000 samples. Interested contractors must have active registration in the System for Award Management, and the solicitation is expected to be available on SAM.gov around December 16, 2024. For further inquiries, potential bidders can contact David Santimaw at zgm2@cdc.gov or 770-488-5282, or Arianna Williams at xsm2@cdc.gov or 770-488-5036.
    Storage of NHANES Biospecimen Samples
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified small businesses to provide services for the storage and management of approximately 500,000 biospecimen samples from the National Health and Nutrition Examination Survey (NHANES). The contractor will be responsible for receiving, securely storing, inventorying, and shipping these samples, while ensuring compliance with health regulations and maintaining the integrity of the samples throughout the contract period from March 15, 2025, to March 14, 2030. This procurement is critical for supporting future health research and maintaining public health data integrity, with a focus on quality assurance and confidentiality. Interested parties must submit their proposals electronically, adhering to specific guidelines, with the solicitation anticipated to be posted on SAM.gov around December 09, 2024. For further inquiries, potential offerors can contact Amy Holder at zts0@cdc.gov or Arianna Williams at xsm2@cdc.gov.
    Storage of NHANES Biospecimen Samples
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals from qualified small businesses for the storage and management of approximately 500,000 NHANES biospecimen samples. The contractor will be responsible for receiving, storing, and shipping samples, as well as providing additional services such as freezer maintenance, inventory management, reporting, sample disposal, and decontamination. This procurement is critical for maintaining the integrity of public health research and data collection efforts, with a contract expected to be awarded as a Firm Fixed Price Indefinite Delivery/Indefinite Quantity (IDIQ) type, including a one-year base period and four one-year option periods. Interested parties must ensure they have an active registration in the System for Award Management (SAM) and are encouraged to submit proposals following the anticipated solicitation posting on SAM.gov around December 09, 2024. For further inquiries, contact Amy Holder at zts0@cdc.gov or Arianna Williams at xsm2@cdc.gov.
    NCI OA Special Notice of Subcontract Opportunity at the Frederick National Laboratory for Cancer Research
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Cancer Institute (NCI), has issued a Special Notice regarding a subcontract opportunity at the Frederick National Laboratory for Cancer Research (FNLCR) aimed at enhancing laboratory practices to meet Good Clinical Laboratory Practice (GCLP) standards. The primary objective is to engage a subcontractor to evaluate current laboratory operations, identify compliance gaps, and implement improvements related to sample management, data integrity, and overall laboratory quality standards. This initiative is crucial for ensuring the integrity of testing and data management, which will facilitate the approval of new vaccine recommendations and enhance the laboratory's quality management system. Interested parties should note that this notice is for informational purposes only, with responses treated as government property, and are encouraged to monitor SAM.gov for updates. The deadline for submissions is January 3, 2025, at noon EST, and inquiries can be directed to Jennifer Gnuschke at jennifer.gnuschke@nih.gov.
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    NIAID Virology Quality Assurance
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a comprehensive quality assurance program for virologic assays related to HIV and other viral pathogens. The objective is to ensure the validity and comparability of laboratory data through proficiency testing panels and real-time assay controls, which are critical for ongoing and future studies on infectious diseases. This program has been operational since 1988 and supports approximately 110 laboratories globally, emphasizing the importance of maintaining high standards in virologic testing. Proposals are expected to be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website, with the solicitation anticipated to be available on or about January 9, 2025. For further inquiries, interested parties can contact Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov.
    Werfen USA LLC Various Consumables and lease of two ACL Top 750 Instruments for the Department of Laboratory Medicine at the NIH Clinical Center
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a firm fixed price purchase order to Werfen USA LLC for various consumables and the lease of two ACL Top 750 instruments for the Department of Laboratory Medicine at the NIH Clinical Center. This acquisition aims to extend the lease of the ACL TOP 750 analyzers, which are critical for conducting routine and specialized coagulation tests in mid to high-volume clinical laboratories, enhancing lab efficiency and result reliability. Interested parties may submit their capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by December 27, 2024, 6:30 AM EST, with the total contract value not exceeding $250,000, as this procurement is being conducted under Simplified Acquisition Procedures.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug products. The objective of this procurement is to secure high-quality formulated drug products to support preclinical, IND-enabling, and clinical studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is critical for advancing therapeutic development and enhancing the drug development pipeline, which is vital for public health. Proposals are due by February 3, 2025, with a contract period extending from September 30, 2025, to July 31, 2031, and a maximum funding amount of $49,885,703. Interested parties can reach out to Michelle Cecilia at michelle.cecilia@nih.gov or Valerie Whipple at valerie.whipple@nih.gov for further information.
    NIAID CLINICAL PRODUCTS CENTER (CPC)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for a contract to provide pharmacy and pharmaceutical oversight for clinical trials, both nationally and internationally. The primary objective of this contract is to ensure the integrity of study products, participant safety, and compliance with pharmacy and pharmaceutical regulations throughout various NIH-funded clinical trials. This opportunity is critical for maintaining high standards in public health research, as it encompasses a wide range of services including product management, regulatory document maintenance, and clinical laboratory testing. Proposals are due by January 17, 2025, with the contract expected to commence on April 1, 2026, and run through March 31, 2027, potentially extending through 2033. Interested parties can contact Deborah Blyveis at blyveisd@niaid.nih.gov or Emily Bannister at emily.bannister@nih.gov for further information.
    Clinical & Laboratory Standards Institute membership
    Active
    Commerce, Department Of
    The National Institute of Standards and Technology (NIST) intends to negotiate a sole source contract for a membership with the Clinical & Laboratory Standards Institute (CLSI) located in Berwyn, PA. This membership is crucial for NIST's Chemical Sciences Division, which relies on CLSI's extensive database to develop technical standards for the healthcare community, ensuring that NIST remains aligned with best practices in clinical laboratory testing. The resulting order will be a Firm-Fixed Price purchase order under NAICS code 561330, with a small business size standard of $36.5 million. Interested parties capable of fulfilling these requirements are invited to submit responses by December 24, 2024, with inquiries directed to Erik Frycklund at erik.frycklund@nist.gov or Donald Graham at donald.graham@nist.gov.